Single and chronic dose pharmacokinetic studies of sodium valproate in epileptic patients

Gibaldi, M. and Perrier, D.: Pharmacokinetics. In: Drugs and the pharmaceutical sciences, Vol. 1, J. Swarbrick (ed). New York: Marcel Dekker, 1975

Gugler, R., Schell, A., Eichelbaum, M., Froscher, W., Schulz, H. U.: Disposition of valproic acid in man. Eur. J. Clin. Pharmacol.12, 125?132 (1977)

Klotz, U., Antonin, K. H.: Pharmacokinetics and bioavailability of sodium valproate. Clin. Pharmacol. Ther.21, 736?743 (1977)

Loisseau, P., Brachet, A., Henry, P.: Concentration of dipropylacetate in plasma. Epilepsia16, 609?615 (1975)

Meinardi, H.: Clinical trials of antiepileptic drugs. Psychiatr. Neurol. Neurochir.74, 141?151 (1971)

Meunier, G., Carraz, G., Meunier, U., Eymard, P., Aimard, M.: Properties pharmacodynamiques de l'acide n-dipropylacetique. Therapie18, 435?438 (1963)

Monks, A., Boobis, S., Wadsworth, J., Richens, A.: Plasma protein binding interaction between phenytoin and valproic acid in vitro. Br. J. Clin. Pharmacol.6, 487?492 (1978)

Perucca, E., Gatti, G., Frigo, G. M., Crema, A.: Pharmacokinetics of valproic acid after oral and intravenous administration. Br. J. Clin. Pharmacol.5, 313?318 (1978a)

Perucca, E., Gatti, G., Frigo, G. M., Crema, A., Calzetti, S., Visintini, D.: Disposition of sodium valproate in epileptic patients. Br. J. Clin. Pharmacol.5, 495?499 (1978b)

Pinder, R. M., Brodgen, R. N., Speight, T. M., Avery, G. S.: Sodium valproate: A review of its pharmacological properties and therapeutic efficacy in epilepsy. Drugs13, 81?123 (1977)

Richens, A., Ahmad, S.: Controlled trial of sodium valproate in severe epilepsy. Br. Med. J.1975/IV, 255?256

Richens, A., Scoular, I. T., Ahmad, S., Jordan, B. J.: Pharmacokinetics and efficacy of epilim in patients receiving long-term therapy with other antiepileptic drugs. In: Clinical and pharmacological aspects of sodium valproate (Epilim) in the treatment of epilepsy. N. J. Legg, (ed.) pp. 78?88. Turnbridge: MCS Consultants 1976

Simon, D., Penry, J. K.: Sodium Di-N-propylacetate (DPA) in the treatment of epilepsy ? a review. Epilepsia16, 549?573 (1975)

Suzuki, M., Maruyama, H., Ishibashi, Y., Ogawa, S., Seki, T., Hoshino, M., Maekawa, J., Yo, T., Sato, Y.: A double blind comparative trial of sodium dipropylacetate and ethosuximide in epilepsy in children, with special emphasis on pure petit mal seizures (In Japanese) Med. Prog.. (Japan)82, 470?488 (1972)

Vajda, F., Drummer, O., Morris, P., McNeil, J., Bladin, P.: Gas chromatographic measurement of plasma levels of sodium valproate: Tentative therapeutic range of a new anticonvulsant in the treatment of refractory epileptics. Clin. Exp. Pharmacol. Physiol.5, 67?73 (1978a)

Vajda, F., Mihaly, G., Miles, J., Morris, P., Bladin, P.: Sodium valproate: Dose-plasma level relationships and interdose fluctuations. Clin. Exp. Neurol. (in press 1978b)